Legislator Giurisprudenza & Legislazione
DE FR IT EN
Analizza in Legislator
173.413.2 KR-PATGERFP-TFBSPG-TFB CH

Art. 2 Regolamento del 28 settembre 2011 sulle spese giudiziarie presso il Tribunale federale dei brevetti (SpG-TFB) - Procedura sommaria

SpG-TFB
Apri la fonte ufficiale Atto completo (17 Articoli) Versione Markdown leggibile dalle macchine (.md)

Art. 2 SpG-TFB · Procedura sommaria

Nella procedura sommaria la tassa può essere ridotta della metà al massimo.

La tassa per la ricezione di una memoria difensiva ammonta a 1000–2000 franchi.

← Art. 1 SpG-TFB Regolamento del 28 settembre 2011 sulle spese giudiziarie presso il Tribunale federale dei brevetti (SpG-TFB) - Tasse di giustizia secondo il valore litigioso Art. 3 SpG-TFB →

Ti chiedi come si applica questa disposizione alla tua fattispecie?

Analizza questa norma insieme alla giurisprudenza, ai commentari e alle disposizioni correlate in Legislator AI.

Apri in Legislator →

Decisioni giudiziarie che applicano questa disposizione (24)

S2023-011 (Art. 2 Abs. 1 KR-PatGer)
Ferinject® Patent Dispute: Balancing Disclosure and Confidentiality
Cited for determining the court fee based on the disputed value.
S2024-002 (art. 1 al. 1 et 2, et art. 2 al. 1 FP-TFB)
Patent Infringement of Buccal Device for Facial Growth
Cited in the reasoning regarding the court fees, but not explicitly in the dispositive.
S2023-004--S2023-005 (Art. 2 KR-PatGer)
E-bike Manufacturer Enjoined from Selling Infringing E-bikes
This provision was cited in relation to the determination of court fees based on the value of the dispute.
S2023-007 (art. 2 al. 1 FP-TFB)
Patent Holder's Claims Against Licensee Denied Over Wind Technology Dispute
Used to determine the judicial fee based on the value in dispute.
S2023-006 (Art. 1 Abs. 1 i.V.m. Art. 2 Abs. 1 KR-PatGer)
Pharma Co. v. Competitor: Preliminary Injunction Denied Over Rivaroxaban Patent
The court fee was determined based on the dispute value.
S2023-002 (Art. 1 und 2 KR-PatGer)
Patent Infringement: Description Order and Trade Secrets
Used to determine the court fee based on the value of the description.
S2023-001 (Art. 2 Abs. 1 KR-PatGer)
Patent Application Transfer Restricted Pending Ownership Dispute
Cited for the calculation of court fees based on the value of the dispute.
S2021-003 (Art. 2 KR-PatGer)
Patent Holder v. Competitor: Injunction Granted for Scaffolding Frame Infringement
Basis for determining court costs.
S2019-007 (Art. 2 Abs. 1 KR-PatGer)
Johnson & Johnson v. Mylan Pharmaceuticals Inc.
Determines court fees based on the claim value.
S2018-007 (Art. 1 Abs. 1 i.V.m. Art. 2 Abs. 1 KR-PatGer)
Injunction Denied: Patent Claims Likely Invalid Due to Prior Art
Basis for the calculation of court fees.
S2019-004 (Art. 2 Abs. 1 KR-PatGer)
Patent Holder's Delay Undermines Preliminary Injunction Claim
Used to determine the court fee based on the litigation value and the fact that a three-judge panel was not required.
S2018-004 (Art. 2 KR-PatGer)
Abacavir/Lamivudine Combination Patent Infringement Preliminary Injunction
Cited in the dispositive for setting the court fee.
S2018-002 (Art. 1 i.V.m. Art. 2 KR-PatGer)
Patent Infringement Provisional Measures Denied Due to Lack of Urgency and Proof
Basis for determining the court fee based on the undisputed dispute value.
S2017-006 (Art. 2 KR-PatGer)
Patent Holder Obtains Preliminary Injunction Against Generic Drug Manufacturer Based on SPC
Cited in the dispositive for the determination of court fees.
S2017-003 (art. 2 al. 1 FP-TFB)
Provisional Measures Granted to Prevent Patent Withdrawal/Amendment Pending Infringement Determination
Cited in relation to the calculation of judicial fees.